Ungaro, R., S. Mehandru, P.B. Allen, et al. 2017. Ulcerative colitis. Lancet 389 (10080): 1756–1770.
Conrad, K., D. Roggenbuck, and M.W. Laass. 2014. Diagnosis and classification of ulcerative colitis. Autoimmunity Reviews 13 (4–5): 463–466.
Article PubMed CAS Google Scholar
Ng, S.C., H.Y. Shi, N. Hamidi, et al. 2017. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390 (10114): 2769–2778.
Hauso, Ø., T.C. Martinsen, and H. Waldum. 2015. 5-Aminosalicylic acid, a specific drug for ulcerative colitis. Scandinavian Journal of Gastroenterology 50 (8): 933–941.
Article PubMed CAS Google Scholar
Bonovas, S., K. Pantavou, D. Evripidou, et al. 2018. Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses. Best Practice & Research Clinical Gastroenterology 32–33: 43–47.
Umehara, Y., M. Kudo, R. Nakaoka, et al. 2006. Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepato-Gastroenterology 53 (72): 879–882.
Neurath, M.F., S. Finotto, I. Fuss, et al. 2001. Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question. Trends in Immunology 22 (1): 21–26.
Article PubMed CAS Google Scholar
Kusugami, K., A. Fukatsu, M. Tanimoto, et al. 1995. Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Digestive Diseases and Sciences 40 (5): 949–959.
Article PubMed CAS Google Scholar
Olsen, T., R. Goll, G. Cui, et al. 2009. TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis. Cytokine 46 (2): 222–227.
Article PubMed CAS Google Scholar
Page, M.J., J. Bester, and E. Pretorius. 2018. The inflammatory effects of TNF-α and complement component 3 on coagulation. Science and Reports 8 (1): 1812.
Farina, G., R. Lemaire, P. Pancari, et al. 2009. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Annals of the Rheumatic Diseases 68 (3): 435–441.
Article PubMed CAS Google Scholar
Schulz, J.N., J. Nüchel, A. Niehoff, et al. 2016. COMP-assisted collagen secretion–a novel intracellular function required for fibrosis. Journal of Cell Science 129 (4): 706–716.
Szondy, Z., and A. Pallai. 2017. Transmembrane TNF-alpha reverse signaling leading to TGF-beta production is selectively activated by TNF targeting molecules: Therapeutic implications. Pharmacological Research 115: 124–132.
Article PubMed CAS Google Scholar
Xu, H., Q. Li, Y. Zhao, et al. 2016. Intestinal NHE8 is highly expressed in goblet cells and its expression is subject to TNF-α regulation. American Journal of Physiology. Gastrointestinal and Liver Physiology 310 (2): G64-69.
Musch, M.W., L.L. Clarke, D. Mamah, et al. 2002. T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. The Journal of Clinical Investigation 110 (11): 1739–1747.
Article PubMed PubMed Central CAS Google Scholar
Li, X., Z. Wu, X. Fu, et al. 2013. Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases. Medicinal Research Reviews 33 (3): 517–553.
Ma, Z., Y.Y. Wang, H.W. Xin, et al. 2019. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells. International Journal of Biochemistry & Cell Biology 108: 17–20.
Ashrafizadeh, M., A. Zarrabi, E. Mostafavi, et al. 2022. Non-coding RNA-based regulation of inflammation. Seminars in Immunology 59: 101606.
Article PubMed CAS Google Scholar
Chew, C.L., S.A. Conos, B. Unal, et al. 2018. Noncoding RNAs: Master Regulators of Inflammatory Signaling. Trends in Molecular Medicine 24 (1): 66–84.
Article PubMed CAS Google Scholar
Chen, S.W., P.Y. Wang, Y.C. Liu, et al. 2016. Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis. Inflammatory Bowel Diseases 22 (11): 2582–2592.
Padua, D., S. Mahurkar-Joshi, I.K. Law, et al. 2016. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology 311 (3): G446-457.
Article PubMed PubMed Central Google Scholar
Akıncılar, S.C., L. Wu, Q.F. Ng, et al. 2021. NAIL: An evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis. Gut 70 (10): 1857–1871.
Congrains, A., K. Kamide, M. Ohishi, et al. 2013. ANRIL: Molecular mechanisms and implications in human health. International Journal of Molecular Sciences 14 (1): 1278–1292.
Article PubMed PubMed Central CAS Google Scholar
Zhang, D., G. Sun, H. Zhang, et al. 2017. Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomedicine & Pharmacotherapy 85: 511–516.
Royds, J.A., A.P. Pilbrow, A. Ahn, et al. 2015. The rs11515 Polymorphism Is More Frequent and Associated With Aggressive Breast Tumors with Increased ANRIL and Decreased p16 (INK4a) Expression. Frontiers in Oncology 5: 306.
Mirza, A.H., C.H. Berthelsen, S.E. Seemann, et al. 2015. Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med 7 (1): 39.
Article PubMed PubMed Central Google Scholar
Olsen, J., T.A. Gerds, J.B. Seidelin, et al. 2009. Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflammatory Bowel Diseases 15 (7): 1032–1038.
Funakoshi, T., K. Yamashita, N. Ichikawa, et al. 2012. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice. Journal of Crohn’s & Colitis 6 (2): 215–225.
Dieleman, L.A., M.J. Palmen, H. Akol, et al. 1998. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clinical and Experimental Immunology 114 (3): 385–391.
Article PubMed PubMed Central CAS Google Scholar
Lu, J.W., A. Rouzigu, L.H. Teng, et al. 2021. The Construction and Comprehensive Analysis of Inflammation-Related ceRNA Networks and Tissue-Infiltrating Immune Cells in Ulcerative Progression. BioMed Research International 2021: 6633442.
Article PubMed PubMed Central Google Scholar
Beyer, M., Y. Thabet, R.U. Müller, et al. 2011. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nature Immunology 12 (9): 898–907.
Article PubMed PubMed Central CAS Google Scholar
Kondo, M., Y. Tanaka, T. Kuwabara, et al. 2016. SATB1 Plays a Critical Role in Establishment of Immune Tolerance. The Journal of Immunology 196 (2): 563–572.
Article PubMed CAS Google Scholar
Yarani, R., A.H. Mirza, S. Kaur, et al. 2018. The emerging role of lncRNAs in inflammatory bowel disease. Experimental & Molecular Medicine 50 (12): 1–14.
Chapman, C.G., and J. Pekow. 2015. The emerging role of miRNAs in inflammatory bowel disease: A review. Therap Adv Gastroenterol 8 (1): 4–22.
Article PubMed PubMed Central Google Scholar
Fernandes, J.C.R., S.M., Acuña, J.I. Aoki, et al. (2019). Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease. Noncoding RNA, 5(1).
Makeyev, E.V., and T. Maniatis. 2008. Multilevel regulation of gene expression by microRNAs. Science 319 (5871): 1789–1790.
Article PubMed PubMed Central CAS Google Scholar
Godnic, I., M. Zorc, D. Jevsinek Skok, et al. 2013. Genome-wide and species-wide in silico screening for intragenic MicroRNAs in human, mouse and chicken. PLoS ONE 8 (6): e65165.
Article PubMed PubMed Central CAS Google Scholar
Zacharopoulou, E., M. Gazouli, M. Tzouvala, et al. 2017. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Digestive and Liver Disease 49 (10): 1067–1072.
Article PubMed CAS Google Scholar
Xia, H., S. Li, Y. He, et al. 2022. Long non-coding RNA ANRIL serves as a potential marker of disease risk, inflammation, and disease activity of pediatric inflammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology 46 (4): 101895.
Comments (0)